Scientists in SDI Debate Look for Middle Ground

ALBUQUERQUE, N.M.—University of New Mexico physicist Charles Bickel admits to being surprised by his encounter last summer with Roger Hagengruber, vice president for exploratory systems at Sandia National Laboratories. "I had suspected we were further apart on SDI," he said. The revelation came as the two physicists participated in the Trinity Conference last June in Santa Fe. Before a public forum and assisted by a mediator, they engaged in a process called "dialoguing." After stating the

Written byLouis Weisberg
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The revelation came as the two physicists participated in the Trinity Conference last June in Santa Fe. Before a public forum and assisted by a mediator, they engaged in a process called "dialoguing." After stating their views on SDI, they were encouraged to look for points of agreement. Despite the fact that Bickel believes the country spends too much on defense and Hagengruber thinks defense expenditures are justified, the two ultimately agreed that the level of SDI funding is unwarranted given the current level of knowledge.

Santa Fe's Trinity Forum, which sponsored the event, is one of three grassroots organizations that have tackled the bitter controversy surrounding the Strategic Defense Initiative and research into nuclear weapons in this country by a series of conferences and community forums aimed at narrowing the differences among scientists.

The attempt to hold a dialogue on nuclear weapons was begun five years ago by a ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies